EURACTIV - Belgium's biotech sector has the science but not the scale, according to a new PwC whitepaper, which argues that the country must operate as one ecosystem if startups are to grow. Read more
Nicole Verbeeck is an independent health journalist covering health and life sciences in Europe. Alongside her reporting, she leads an editorial studio specializing in journalism, editorial work and creative editorial formats.
Independent journalism
Reporting on health and life sciences in Europe for:
Euractiv (Advocacy Lab)
EU Perspectives
European Biotechnology Magazine
APM Market Access
Editorial studio in health & life sciences
Creative editorial projects
Latest articles
EU PERSPECTIVES - Europe's share of global clinical trials has been cut in half in just a decade, while China has surged ahead. As Ireland takes over the EU presidency on Wednesday, Dublin is betting that faster drug approvals, biotech reforms and health investment can restore Europe's competitiveness — and determine how quickly patients get...
EURACTIV - Belgian Prime Minister Bart De Wever has told policymakers he wants to restart the R&D Biopharma platform after the summer. He played down talk of crisis, a day after warning – at the anniversary of Novartis's Puurs site in Belgium – that Europe is losing ground to the United States and China. Read more
‘More monopoly doesn’t mean more innovation’: Lawmakers move to scrap biotech patent perk
26-06-2026
EU PERSPECTIVES - Two European Parliament committees have moved to delete the Biotech Act's most contested measure: a proposed 12-month extension of market protection for biotech medicines. Read more
